Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy (semaglutide) significantly reduces appetite, and some people worry that eating much less means their body is being starved of what it needs. That concern is understandable, and worth taking seriously. Malnutrition from Wegovy is not an inevitable outcome, but it is a real risk if nutrition isn't actively managed alongside treatment. These medicines are prescription-only, and a prescriber assesses your full health picture before and during treatment — precisely because questions like this matter.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The biggest misunderstanding around Wegovy and malnutrition is the idea that the medicine is somehow draining nutrients directly, or that serious deficiency is a predictable side effect for most people. That's not what the evidence shows. To understand precisely what you're taking, it helps to read the semaglutide definition page, which explains that Wegovy works by slowing gastric emptying and reducing appetite signals, so people feel full sooner and eat less. The medicine doesn't interfere with how nutrients are absorbed once food is actually eaten.
The risk comes from what happens downstream. When appetite drops sharply, many people find themselves eating far less than before, sometimes to a point where total protein, iron, calcium, vitamin D and B vitamins fall short, simply because there's less food going in. That's a meaningful distinction. It means the risk is manageable, but only if you treat nutrition as part of the treatment, not an afterthought.
Our clinical team at nume will discuss nutritional considerations as part of your assessment, but day-to-day eating choices remain yours to shape. For a thorough look at how semaglutide behaves in the body, the mechanism of action page has more detail.
Not everyone on Wegovy faces the same level of nutritional risk. A few specific situations raise it considerably. People who were already eating a narrow or low-nutrient diet before starting treatment face a higher baseline risk because there is less nutritional margin to work with once appetite falls. Those who experience persistent nausea or vomiting (common enough in the early titration period) may struggle to keep food down consistently, compounding the problem.
Muscle loss is the most clinically significant concern at population level. When total calorie intake drops fast, the body can break down lean muscle mass for energy if dietary protein is inadequate. Clinical trial data consistently show that people using GLP-1 medicines lose a higher proportion of lean mass than they would with lifestyle changes alone. That's why protein (and strength-based physical activity) are routinely emphasised alongside treatment.
Hair thinning is another signal patients often notice at the three-to-six-month mark. It's typically a stress response to rapid weight loss (known as telogen effluvium) rather than a sign of a specific deficiency, but it can indicate that intake has dropped too far too fast. If you notice significant hair shedding, mention it at your next review.
There's also a more subtle risk: people who feel fine subjectively but are quietly running low on iron, B12 or vitamin D. These deficiencies don't always announce themselves early. For guidance on what to eat alongside treatment, the Wegovy nutrition plan page sets out practical priorities.
When appetite is blunted, every meal carries more nutritional responsibility. A 500-calorie portion eaten when you're barely hungry needs to do the job that 1,200 calories would have done before. That means choosing foods with a high nutrient density: eggs, fish, lean meat, legumes, dairy, leafy vegetables. Ultra-processed foods and snacks that are high in energy but low in micronutrients become a worse trade-off than they were before.
Protein is the single most important macronutrient to protect. UK guidance generally suggests aiming for around 1.2–1.6g of protein per kilogram of body weight for people in active weight-loss phases, though your prescriber or a dietitian can give you a target that fits your specific situation. Staying well hydrated matters too, especially during periods of nausea when fluids are easiest to manage.
Wegovy is licensed for use alongside a reduced-calorie diet and increased physical activity, per the NHS semaglutide information, the dietary component isn't a bonus recommendation, it's built into how the medicine is supposed to work. A brief look at what Wegovy contains helps explain why the absorption mechanism is distinct from any nutritional depletion effect.
Most people on Wegovy don't develop clinical malnutrition, but catching the warning signs early matters. Fatigue that doesn't improve as the body adjusts to treatment, weakness, persistent dizziness, difficulty concentrating, significant hair loss, slow wound healing and recurrent infections can all be worth raising with a prescriber. They're not always nutrition-related, but they shouldn't be dismissed either.
The MHRA's Yellow Card scheme allows patients to report unexpected side effects from any licensed medicine, including nutritional concerns that don't fit the usual side-effect profile. And if persistent nausea is the underlying problem, that's worth addressing directly rather than managing with smaller and smaller meals. Our page on Wegovy and gastritis explores related gut symptoms in more detail.
If you're considering Wegovy and want to talk through how treatment would be supervised, including nutritional support, you can start a free consultation with one of our GPhC-registered prescribers. There's no obligation, and a real clinician reads your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.